Stock listing
BOATS:ASND Ascendis Pharma A/S Stock
US listing (BOATS) of Ascendis Pharma A/S · home listing NASDAQ:ASND
Follow Ascendis Pharma A/S into a list and get an email when it puts out news.
Home listing price · NASDAQ:ASND
$251.27 USD -1.73 (-0.7%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ASND
- Day range
- $249.55 – $255.61 USDOct 30, 2026
- Volume
- 386,682 sharesOct 30, 2026
- Market cap
- $16.53B USDAt the close on Oct 30, 2026 · price × 65.80M shares outstanding
- 52-week range
- $188.07 – $282.15 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $168.6M USDMedian day 609,150 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ASND · Home | $251.27 USD | -1.73 (-0.7%) | 386,682 | $253.50 | $255.61 | $249.55 | $253.00 | Close on Oct 30, 2026 |
| B3:A1SN34 | 80.64 BRL | +4.16 (+5.4%) | 70 | 80.83 | 80.83 | 80.56 | 76.48 | Close on Oct 22, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ASND · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $251.27 | -1.73 | -0.7% | $253.50 | $255.61 | $249.55 | 386,682 | |
| $253.00 | +3.45 | +1.4% | $250.62 | $254.20 | $249.56 | 491,400 | |
| $249.55 | +3.70 | +1.5% | $246.05 | $249.88 | $243.45 | 660,200 | |
| $245.85 | +0.70 | +0.3% | $243.26 | $246.58 | $242.51 | 599,100 | |
| $245.15 | +1.78 | +0.7% | $243.56 | $246.40 | $243.35 | 545,000 | |
| $243.37 | +0.38 | +0.2% | $242.00 | $244.58 | $240.79 | 575,500 | |
| $242.99 | +4.09 | +1.7% | $239.38 | $243.87 | $236.87 | 539,200 | |
| $238.90 | +4.57 | +2.0% | $236.00 | $240.21 | $235.50 | 662,100 | |
| $234.33 | +4.38 | +1.9% | $230.19 | $235.88 | $229.88 | 394,700 | |
| $229.95 | +4.70 | +2.1% | $227.44 | $233.19 | $225.81 | 1,268,100 | |
| $225.25 | -1.37 | -0.6% | $226.62 | $226.76 | $223.78 | 680,300 | |
| $226.62 | -0.38 | -0.2% | $230.40 | $234.01 | $226.06 | 404,000 | |
| $227.00 | +3.79 | +1.7% | $222.54 | $227.83 | $222.00 | 995,700 | |
| $223.21 | -3.79 | -1.7% | $225.99 | $228.91 | $222.21 | 592,200 | |
| $227.00 | -2.23 | -1.0% | $229.00 | $229.23 | $226.66 | 667,400 | |
| $229.23 | +6.54 | +2.9% | $225.08 | $233.96 | $223.96 | 815,700 | |
| $222.69 | -5.72 | -2.5% | $227.83 | $227.98 | $219.52 | 924,100 | |
| $228.41 | +2.36 | +1.0% | $224.36 | $229.00 | $223.05 | 820,500 | |
| $226.05 | -1.98 | -0.9% | $229.21 | $230.91 | $222.72 | 1,091,800 | |
| $228.03 | +0.16 | +0.1% | $229.66 | $230.73 | $226.84 | 783,200 | |
| $227.87 | +0.56 | +0.2% | $227.63 | $229.02 | $225.20 | 641,400 | |
| $227.31 | -0.52 | -0.2% | $228.03 | $229.88 | $226.00 | 805,900 | |
| $227.83 | -0.24 | -0.1% | $227.97 | $230.97 | $226.18 | 926,200 | |
| $228.07 | -1.98 | -0.9% | $227.42 | $229.89 | $223.70 | 741,900 | |
| $230.05 | +4.45 | +2.0% | $226.00 | $231.14 | $224.81 | 747,500 | |
| $225.60 | -5.10 | -2.2% | $230.13 | $230.43 | $224.26 | 420,000 | |
| $230.70 | +7.57 | +3.4% | $223.00 | $231.13 | $220.23 | 1,165,600 | |
| $223.13 | -14.44 | -6.1% | $236.83 | $237.98 | $220.60 | 1,218,200 | |
| $237.57 | -0.02 | 0.0% | $239.09 | $240.69 | $234.67 | 548,300 | |
| $237.59 | +0.87 | +0.4% | $238.66 | $241.51 | $237.00 | 823,000 | |
| $236.72 | -2.32 | -1.0% | $238.15 | $243.68 | $236.02 | 1,558,800 | |
| $239.04 | -8.65 | -3.5% | $249.23 | $249.23 | $237.13 | 1,099,500 | |
| $247.69 | +7.92 | +3.3% | $239.70 | $249.01 | $237.23 | 1,260,000 | |
| $239.77 | -25.15 | -9.5% | $257.17 | $257.53 | $228.56 | 2,961,200 | |
| $264.92 | +1.405 | +0.5% | $265.00 | $265.50 | $260.00 | 416,300 | |
| $263.52 | +2.285 | +0.9% | $263.34 | $266.34 | $259.48 | 443,600 | |
| $261.23 | +0.42 | +0.2% | $260.00 | $262.17 | $258.01 | 504,900 | |
| $260.81 | -9.28 | -3.4% | $270.89 | $272.37 | $260.75 | 497,400 | |
| $270.09 | -0.47 | -0.2% | $263.41 | $272.47 | $262.32 | 653,300 | |
| $270.56 | -0.56 | -0.2% | $267.96 | $271.14 | $265.22 | 723,500 | |
| $271.12 | +3.81 | +1.4% | $266.94 | $272.44 | $265.80 | 1,018,500 | |
| $267.31 | +7.06 | +2.7% | $261.39 | $268.71 | $257.52 | 418,300 | |
| $260.25 | -2.79 | -1.1% | $261.65 | $266.63 | $256.28 | 610,600 | |
| $263.04 | +15.13 | +6.1% | $247.65 | $268.98 | $247.65 | 1,025,900 | |
| $247.91 | -1.45 | -0.6% | $248.11 | $250.23 | $246.30 | 314,800 | |
| $249.36 | -0.89 | -0.4% | $249.73 | $250.69 | $248.41 | 189,500 | |
| $250.25 | -2.74 | -1.1% | $252.84 | $252.84 | $249.16 | 237,400 | |
| $252.99 | +1.04 | +0.4% | $253.01 | $256.60 | $251.33 | 333,518 | |
| $251.95 | -1.34 | -0.5% | $256.35 | $256.35 | $247.03 | 329,923 | |
| $253.29 | -1.52 | -0.6% | $253.62 | $257.89 | $252.87 | 363,800 | |
| $254.81 | -4.81 | -1.9% | $256.65 | $260.98 | $253.21 | 533,600 | |
| $259.62 | +10.77 | +4.3% | $255.00 | $261.61 | $251.11 | 541,200 | |
| $248.85 | +1.45 | +0.6% | $246.47 | $253.55 | $245.68 | 452,600 | |
| $247.40 | -1.10 | -0.4% | $246.33 | $250.62 | $242.00 | 607,700 | |
| $248.50 | +2.27 | +0.9% | $243.63 | $249.52 | $240.64 | 650,400 | |
| $246.23 | -9.23 | -3.6% | $250.38 | $251.43 | $244.12 | 1,060,600 | |
| $255.46 | +0.89 | +0.3% | $253.92 | $258.55 | $251.92 | 439,800 | |
| $254.57 | -1.05 | -0.4% | $256.70 | $258.48 | $252.26 | 418,500 | |
| $255.62 | +0.21 | +0.1% | $255.01 | $257.42 | $251.00 | 423,500 | |
| $255.41 | +5.56 | +2.2% | $251.76 | $257.57 | $251.76 | 325,500 | |
| $249.85 | +5.65 | +2.3% | $244.70 | $254.98 | $244.70 | 746,600 | |
| $244.20 | -0.39 | -0.2% | $246.64 | $249.50 | $243.57 | 486,200 | |
| $244.59 | +1.14 | +0.5% | $245.90 | $247.98 | $239.56 | 791,800 | |
| $243.45 | -0.46 | -0.2% | $244.68 | $245.66 | $239.93 | 622,900 | |
| $243.91 | -7.16 | -2.9% | $249.71 | $252.46 | $243.30 | 508,900 | |
| $251.07 | -0.98 | -0.4% | $250.00 | $253.07 | $245.84 | 475,200 |
- Ticker
- BOATS:ASND
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
TransCon® PTH (Palopegteriparatide) Demonstrates Sustained, Clinically Meaningful Improvements in Kidney Function in Adults with Hypoparathyroidism Treated Up to 5 Years
Latest earnings call · Aug 13, 2026
Ascendis Pharma (NASDAQ:ASND) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Feb 23, 2026
ESG Presentation (February 2026)
Sustainability · 52 slides
Calls
Replays
Ascendis Pharma (NASDAQ:ASND) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 8:00 AM ET
Watch TranscriptAscendis Pharma (NASDAQ:ASND) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:00 AM ET
Watch TranscriptAscendis Pharma (NASDAQ:ASND) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 4:30 PM ET
Watch Transcript
Latest news
TransCon® PTH (Palopegteriparatide) Demonstrates Sustained, Clinically Meaningful Improvements in Kidney Function in Adults with Hypoparathyroidism Treated Up to 5 Years
Oct 26, 2026
Closed $245.15 (+0.7%) on Oct 26, 2026
Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children
Oct 16, 2026
Closed $225.25 (-0.6%) on Oct 16, 2026
Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026
Oct 6, 2026
Closed $226.05 (-0.9%) on Oct 6, 2026
Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases
Sep 14, 2026
Closed $239.77 (-9.5%) on Sep 15, 2026
Ascendis Announces Planned $400 Million Share Repurchase Program
Sep 14, 2026
Closed $239.77 (-9.5%) on Sep 15, 2026
First Infant Data from Ascendis Trial of Once-Weekly TransCon CNP (Navepegritide) Presented at ESPE 2026
Sep 9, 2026
Closed $261.23 (+0.2%) on Sep 10, 2026
Ascendis Pharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Sep 8, 2026
Closed $260.81 (-3.4%) on Sep 9, 2026
Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE 2026
Sep 7, 2026
Closed $270.09 (-0.2%) on Sep 8, 2026
Ascendis and BioMarin Enter Binding Term Sheet for a Global Settlement and License Agreement Related to YUVIWEL® (Navepegritide)
Aug 31, 2026
Closed $263.04 (+6.1%) on Aug 31, 2026
Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
Aug 25, 2026
Closed $250.25 (-1.1%) on Aug 26, 2026
Decks
ESG Presentation (February 2026)
Sustainability · 52 slides · Feb 23, 2026
J.P. Morgan Healthcare Conference 2026
Conference · 30 slides · January 2026
Technical Presentation (October 2025)
Technical · 87 slides · Oct 30, 2025
Technical Presentation (May 2025)
Technical · 84 slides · May 28, 2025
Ascendis Pharma A/S on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 40 in the last 12 months · 59 in all · newest Oct 26, 2026 · oldest 2024
- Calls
- 24 calls with a replay · 24 with a transcript · latest Aug 13, 2026
- Decks
- 30 decks · latest Feb 23, 2026
Where Ascendis Pharma A/S is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ASND · Home listing | NASDAQ | United States | USD |
| LS Exchange:A14M6X | LS Exchange | Germany | EUR |
| gettex:A710 | gettex | Germany | EUR |
| Lang & Schwarz:A14M6X | Lang & Schwarz | Germany | EUR |
| BOATS:ASND · This page | BOATS | United States | USD |
| B3:A1SN34 | B3 | Brazil | BRL |
| Lang & Schwarz:DK0060606333 | Lang & Schwarz | Germany | EUR |
| BMV:ASNDN | BMV | Mexico | MXN |
| BIVA:ASNDN | BIVA | Mexico | MXN |
| BMV:ASND1N | BMV | Mexico | MXN |
| Tradegate:A710 | Tradegate | Germany | EUR |
| Lang & Schwarz:A42ANJ | Lang & Schwarz | Germany | EUR |
| BIVA:ASND1N | BIVA | Mexico | MXN |
| Dusseldorf:A710 | Dusseldorf | Germany | EUR |
| LS Exchange:A42ANJ | LS Exchange | Germany | EUR |
| Munich:A710 | Munich | Germany | EUR |
| Stuttgart:A710 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Ascendis Pharma A/S.